Gelatinase A (MMP-2) plays a prominent role in multiple biologic processes, including wound healing, metastasis and angiogenesis. Prior studies (Harendza, S., Pollock, A. S., 
INTRODUCTION
The individual components of the relatively large matrix metalloproteinase (MMP) gene family play multiple roles in the interaction of cells with their surrounding extracellular matrix. As such, this family of evolutionarily conserved enzymes is intimately involved in the diverse physiologic processes that make up normal growth and development, as well as neoplasia, metastasis, angiogenesis and tissue fibrosis. One member of the MMP gene family, gelatinase A or MMP-2, has received considerable attention as a mediator of tumor angiogenesis and metastatic capability (1) (2) (3) . In addition to the role of gelatinase A in malignancy, this enzyme has an important function in the normal growth and development of soft tissues. For example, gelatinase A-deficient mice develop normally, but have significantly retarded growth rates (4) , and diminished corneal and tumor neo-angiogenesis (5) . One form of the inherited osteolysis (vanishing bone) syndromes was recently found to be the result of a single nucleotide polymorphism in the coding region of the gelatinase A gene, resulting in a phenotype characterized by an absolute lack of gelatinase A synthesis and severe growth and soft tissue deformities (6) .
While gelatinase A regulatory control has been frequently characterized as "constitutive" in nature, examination of gelatinase A patterns of expression during development or disease states is consistent with multiple levels of cellular control. For example, expression of gelatinase A during nephrogenesis, a classic model of branching morphogenesis, is highly regulated in both a spatial and temporal manner (7) . Given these considerations, several groups have attempted to define the transcriptional regulatory elements that provide the cellular-or tissue-specific levels of gelatinase A synthesis. These studies have been performed within both the rat and human genomic contexts and have characterized several motifs operative within defined cellular types (8-12). For example, Qin et al., (13) demonstrated that a proximal, overlapping binding site for transcription factors AP-2, Sp1 and (16) (17) (18) . The polymorphism within the gelatinase B promoter affected transcriptional activity and was associated with an increased risk of severe coronary atherosclerosis (17) .
Given the central role of gelatinase A in multiple physiologic and disease processes, the complexity of its regulatory control, and the examples provided by the interstitial collagenase and gelatinase B studies, we initiated an examination of the promoter region of the human gelatinase A gene for polymorphisms affecting transcriptional regulation. In particular, we wished to test the hypothesis that polymorphisms in the r2 enhancer region or the proximal overlapping AP-2/Sp1 binding site existed and thereby affected the transcriptional regulation of gelatinase A in growth and development or during disease processes. During the course of this study, Price et al. (19) polymorphisms within the highly conserved r2 enhancer region, a G ® A transition was mapped to bp -1575 that was immediately adjacent to a potential half-palindromic estrogen receptor binding site. In this report we detail the population distribution of the -1575 G/A alleles, demonstrate specific interaction of this region with the estrogen receptor-a protein, and that the -1575 G ® A transition, which is linked to the -1306 C®T transition, impairs the transcriptional response of gelatinase A to estrogen receptor binding and is associated with a significant decrease in genetic fitness. In order to confirm the deviation of the -1575G/A transition from apparent HardyWeinberg equilibrium and to gain potential insights into possible sources of selection pressure, a second, independently constituted study group of 959 newborns of North German
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Caucasian background (471 males, 488 females) was assessed. As summarized in Table 2 , the genotype frequencies for the total newborn study group and for the male/female subgroups were virtually the same as observed with the healthy blood donor group. The data also 
DISCUSSION
Gelatinase A is an important component of multiple physiologic and pathophysiologic processes, including cell proliferation, angiogenesis and tumor metastasis (27, 28) . Prior Given the sample sizes used in this study we were able to directly determine genotype and allelic frequencies by observation as opposed to estimation. The nonfunctional -1059G/A allele was found to be distributed within the confines of the Hardy-Weinberg equilibrium, while the functional -1575G/A allele distribution revealed a statistically significant deviation (2.6% AA observed vs. 5.3% AA expected) from the Hardy-Weinberg equilibrium with a corresponding reduction in genetic fitness of 21%. The mean ages of the male and female blood donors were 39 and 38 years, respectively, and given the requirement for general good health in this population, the selection against the AA allele is not likely due to common adult diseases associated with increased mortality. Given the homogeneous nature of the study population with no issues of admixture, it is more reasonable to postulate that the deviation from the expected distribution is related to decreased reproductive or prenatal viability in the AA genotype. This hypothesis is strongly supported by our analysis of a second constructs were denoted pT4-Luc1575G-P and pT4-Luc1575A-P, respectively. All constructs were sequenced to confirm authenticity. 
